Sandrine Lavau‐Denès

ORCID: 0000-0003-4760-1981
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer survivorship and care
  • Nutrition and Health in Aging
  • Cancer Treatment and Pharmacology
  • Breast Cancer Treatment Studies
  • Colorectal Cancer Treatments and Studies
  • Lung Cancer Treatments and Mutations
  • Central Venous Catheters and Hemodialysis
  • Venous Thromboembolism Diagnosis and Management
  • HER2/EGFR in Cancer Research
  • Gastric Cancer Management and Outcomes
  • Childhood Cancer Survivors' Quality of Life
  • Head and Neck Cancer Studies
  • Frailty in Older Adults
  • Chemotherapy-related skin toxicity
  • Advanced Breast Cancer Therapies
  • Gastrointestinal disorders and treatments
  • Monoclonal and Polyclonal Antibodies Research
  • Multiple and Secondary Primary Cancers
  • Oral health in cancer treatment
  • Gastrointestinal Tumor Research and Treatment
  • Pharmaceutical Practices and Patient Outcomes
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Genetic factors in colorectal cancer
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Peptidase Inhibition and Analysis

Université de Limoges
2009-2022

John Wiley & Sons (United States)
2021

Hudson Institute
2021

Centre Hospitalier Universitaire de Limoges
2013-2021

Charles River Laboratories (Netherlands)
2021

Hôpital Dupuytren
2001-2020

Hôpital Universitaire Dupuytren
2012-2020

Centre de Recherche en Cancérologie de Toulouse
2018

Clinique Pasteur
2018

Institut Bergonié
2018

J. Guigay Anne Aupérin Jérôme Fayette Esma Saada‐Bouzid Cédrik Lafond and 95 more Miren Taberna Lionnel Geoffrois Laurent Martin Olivier Capitain Didier Cupissol Hélène Castanie Damien Vansteene Philippe Schafhausen Alison Johnson Caroline Even Christian Sire Sophie Duplomb Camille Evrard Jean‐Pierre Delord Brigitte Laguerre Sylvie Zanetta Cécile Chevassus-Clément Aldéric Fraslin Fanny Louat Laura Sinigaglia Ulrich Keilholz Jean Bourhis Ricard Mesı́a Nabil Baba-Hamed E. Babin G. Béra Sarah BETRIAN-LAGARDE Emmanuel Blot Emmanuelle Bompas Christian Borel Mohamed BOUCHEKOUA L. Bozec Le Moal Amandine Bruyas G. Calais Ioana Carpiuc S. Chapet Thierry Chatellier Bruno Chauffert Sandrine Pacquelet Florian Clatot Oana Zveltlana Cojocarasu Alexandre CORNELLY Alexandre Coutté Pierre Dalloz Franck Darloy Melissa Delhommeau D. De Raucourt C. Debelleix P. Debourdeau Anne Françoise DILLIES-LEGRAIN Pascal Dô Catherine Dubos‐Arvis Agnès Ducoulombier Claude El Kouri Sabrina Falkowski François‐Régis Ferrand Michel Gatineau Radj Gervais L. Gras Pierre Guillet Ali Hasbini Stéphane HENAULT Ruth Gabriela Herrera Gómez F. Huguet Marie Christine Kaminsky Aurélie Lagrange Sandrine Lavau‐Denès H. Le Caer Christine Le Foll G. Lefebvre B. Linot Qian LOPEZ Alain Lortholary Margarida Matias L. Mayache-Badis Floriane Minne Delphine Mollon Eve Marie Neidhardt J. Pavillet Frédéric Peyrade Yohann POINTREAU Jean‐François Ramée Camille RAUCHE Sandrine Richard Claudia Rizzo Frédéric Rolland Friderike SCHLURMANN Laëtitia Stefani Louis Tassy Youssef Tazi Jean‐Christophe Théry Florida TORTI EL ZEIN C. Toullec Jean‐Marc Tourani Philippe Toussaint

10.1016/s1470-2045(20)30755-5 article EN publisher-specific-oa The Lancet Oncology 2021-03-07

Objective We tested the effect of dietary advice dedicated to increase intake in older patients at risk for malnutrition during chemotherapy, versus usual care, on one-year mortality. Method conducted a multicentre, open-label interventional, stratified (centre), parallel randomised controlled trial, with 1∶1 ratio, two-year follow-up. Patients were aged 70 years or treated chemotherapy solid tumour and (MNA, Mini Nutritional Assessment 17–23.5). Intervention consisted diet counselling aim...

10.1371/journal.pone.0108687 article EN cc-by PLoS ONE 2014-09-29
Xavier Pivot Gilles Romieu Marc Debled Jean‐Yves Pierga Pierre Kerbrat and 95 more Thomas Bachelot Alain Lortholary Marc Espié P. Fumoleau Daniel Serin Jean-Philippe Jacquin Christelle Jouannaud María Rios Sophie Abadie‐Lacourtoisie Laurence Venat‐Bouvet L. Cany Stéphanie Catala David Khayat Laëtitia Gambotti Iris Pauporté Céline Faure-Mercier Sophie Paget‐Bailly Julie Henriques Jean Marie Grouin Christine Piprot L. Cals L. Chaigneau Francesca Demarchi Trung Van Nguyen Ulrike Stein Cristian Villanueva Bréau Jl A. Chouahnia Pierre Saintigny François Boué P deSaint-Hilaire I Guimont Nathalie Grossat Bruno Valenza E. Lévy Jacques Médioni Catherine Delbaldo Jean‐Christophe Grenier Damien Pouessel Sandrine Lavau‐Denès Claire Falandry Cécile Fournel-Federico Gilles Freyer Sophie Tartas V. Trillet-Lenoir F. Bons G Auclerc Stéphanie Chièze Nadia Raban C. Tournigand S. Trager-Maury Guilhem Bousquet C. Cuvier Sylvie Giacchetti Adam Hocini C. Lemaignan JL Misset D. Avenin C Beerblock Joseph Gligorov P. Rivera Henri Roché Philippe Bougnoux Nawale Hajjaji Olivier Capitain R. Delva P. Maillart P Soulié Hervé Bonnefoi M Durand Nicolas Madranges L. Mauriac P. Chollet AF Dillies Xavier Durando J P Ferrière C Mouret-Reynier Nabholtz Jm Isabelle Van Praagh P. Cottu Véronique Dièras Axel Durieux M Galotte V. Girre Sébastien Henry Ida Iurisci M Jouve Valérie Laurence L. Mignot Sophie Piperno‐Neumann Patricia Tresca Bruno Coudert Emmanuelle Ferrant F. Mayer AC Vanneuville

10.1016/s0140-6736(19)30653-1 article EN publisher-specific-oa The Lancet 2019-06-01

10.1093/annonc/mdv491 article EN publisher-specific-oa Annals of Oncology 2015-10-21

BackgroundMetastatic colorectal cancer frequently occurs in elderly patients. Bevacizumab combination with front line chemotherapy (CT) is a standard treatment but some concern raised about tolerance of bevacizumab for these The purpose PRODIGE 20 was to evaluate and efficacy according specific end points this population.Patients methodsPatients aged 75 years over were randomly assigned + CT (BEV) versus CT. LV5FU2, FOLFOX FOLFIRI regimen prescribed investigator's choice. composite...

10.1093/annonc/mdx529 article EN cc-by-nc Annals of Oncology 2017-09-27

Small bowel adenocarcinoma (SBA) is a rare tumour. We conducted prospective cohort to describe the prevalence, survival and prognostic factors in unselected SBA patients. The study enrolled patients with all stages of newly diagnosed or recurrent at 74 French centres between January 2009 December 2012. In total, 347 were analysed; median age was 63 years (range 23-90). primary tumour duodenum (60.6%), jejunum (20.7%) ileum (18.7%). prevalence predisposing disease 8.7%, 6.9%, 1.7%, 1.7% 0.6%...

10.1002/ijc.32860 article EN International Journal of Cancer 2020-01-08

Abstract Background Older adults with cancer experience negative long‐term functional effects of both and treatments. Exercise may minimize their age‐related cancer‐related decline. Methods We conducted a multicentre open‐label 12 month randomized clinical trial two parallel arms including participants aged ≥70 years lymphoma or carcinoma requiring curative treatment. The study started at the beginning any phase treatment (surgery, chemotherapy, radiotherapy). usual care group (UCG) received...

10.1002/jcsm.12382 article EN cc-by-nc Journal of Cachexia Sarcopenia and Muscle 2019-03-04

BACKGROUND Treatment strategies for locally advanced breast cancer in elderly patients too frail to receive neoadjuvant chemotherapy and the introduction of new classes drugs early 2000s have led consideration endocrine therapy as a treatment younger hormone receptor (HR)–positive, postmenopausal not eligible primary breast‐conserving surgery (BCS). METHODS This was multicenter, phase 2, randomized trial designed evaluate its objective clinical response rate after up 6 months (NET) alone...

10.1002/cncr.30143 article EN Cancer 2016-06-17

Objectives: Physical activity (PA) programs are recommended for breast cancer care. However, their modalities remain to be discussed. This study determined the best time begin a personalized or adapted program based on cardiopulmonary exercise test function. randomized controlled trial evaluated effect of home-based PA (APA) performed during after treatment cardiorespiratory fitness (CRF) at 12 months. Method: The primary endpoint was peak oxygen consumption (VO 2peak ) months (group A vs C...

10.1177/1534735420969818 article EN cc-by-nc Integrative Cancer Therapies 2020-01-01

Abstract Small bowel adenocarcinoma (SBA) is a rare tumour. Large genomic analyses with prognostic assessments are lacking. The NADEGE cohort has enrolled 347 patients all stage SBA from 2009 to 2012. Next‐generation sequencing investigates the presence of 740 hotspot somatic mutations in panel 46 genes involved carcinogenesis. mismatch repair (MMR) status was assessed by immunochemistry. We have collected 196 tumour samples and 125 had conclusive results for mutation analysis. number 0 9.6%...

10.1002/ijc.33392 article EN International Journal of Cancer 2020-11-13

// David G. Cox 1 , Elsa Curtit 2 Gilles Romieu 3 Pierre Fumoleau 4 Maria Rios 5 Hervé Bonnefoi 6 Thomas Bachelot 7 Patrick Soulié 8 Christelle Jouannaud 9 Hugues Bourgeois 10 Thierry Petit 11 Isabelle Tennevet 12 Assouline 13 Marie-Christine Mathieu 14 Jean-Philippe Jacquin 15 Sandrine Lavau-Denes 16 Ariane Darut-Jouve 17 Jean-Marc Ferrero 18 Carole Tarpin 19 Lévy 20 Valérie Delecroix 21 Véronique Trillet-Lenoir 22 Oana Cojocarasu 23 Jérôme Meunier 24 Jean-Yves Pierga 25 Céline...

10.18632/oncotarget.12669 article EN Oncotarget 2016-10-14

BackgroundA surveillance program was performed in colorectal cancer (CRC) patients after surgery, to diagnose asymptomatic recurrence.AimsTo assess whether 18-FDG positron emission tomography/CT (PET/CT) improved the detection of recurrence during a 3-year follow-up.MethodsA multicentre, two-arm randomised prospective trial comparing different 36-month follow-up strategies. Complete colonoscopy at baseline and 3 years clinical exams with imaging every months. The conventional arm (A)...

10.1016/j.dld.2020.10.012 article EN cc-by-nc-nd Digestive and Liver Disease 2020-11-02
Coming Soon ...